MitoReds™ (Ergothioneine-Amplified Reds Antioxidant Blend — NNB Nutrition)

Evidence Level
Preliminary
3 Clinical Trials
8 Documented Benefits
1/5 Evidence Score

MitoReds™ is NNB Nutrition's antioxidant-rich reds powder built around MitoPrime® (L-ergothioneine). Its antioxidant strength has been measured only in test-tube capacity assays, and no human trial has tested MitoReds itself. Combined with the cellular energy and healthy aging benefits of MitoPrime are nearly 30 different fruit, vegetable, and herbal extracts abundant in vitamins, minerals, active compounds, dietary fiber, and antioxidants. It is the red-focused counterpart to MitoGreens®. Many red and purple fruits have been studied for nitric oxide and blood vessel effects, but that evidence comes from the individual fruits and polyphenols rather than from any study of MitoReds.

Studied Dose MitoPrime ergothioneine 5-25 mg/day (from MitoPrime research).
Active Compound Nearly 30 red/purple fruit, vegetable, and herbal extracts (anthocyanins, proanthocyanidins) + MitoPrime® (L-ergothioneine).

Benefits

High antioxidant capacity in laboratory testing

MitoReds combines MitoPrime (L-ergothioneine) with nearly 30 antioxidant-rich red/purple botanicals — delivering strong antioxidant capacity in laboratory testing. In test-tube capacity assays, ergothioneine scores higher than glutathione, vitamin C, and CoQ10. These are laboratory antioxidant measures, not a measured antioxidant effect in people taking MitoReds.

Cellular energy and mitochondrial support

MitoReds provides cellular energy and healthy aging benefits via MitoPrime ergothioneine's mitochondrial accumulation. The 'Mito' positioning reflects the mitochondrial targeting — addressing cellular energy at its source. Particularly valuable for sports nutrition and longevity applications.

Cardiovascular wellness focus

Red and purple fruits/vegetables traditionally associated with cardiovascular health — anthocyanins from berries support NO production, endothelial function, and vascular health. MitoReds concentrates these effects in supplemental format. Complementary to MitoGreens which is more cognitive/immune-focused.

Healthy aging through antioxidant + Mito stack

MitoReds supports healthy aging through combined antioxidant protection (polyphenols + ergothioneine) and mitochondrial support. Addresses oxidative damage accumulation that drives aging. Multi-mechanism approach more effective than single-ingredient interventions for the complex aging process.

Vitamin, mineral, and fiber profile

Nearly 30 fruit, vegetable, and herbal extracts abundant in vitamins, minerals, active compounds, dietary fiber, and antioxidants. Multi-nutrient profile provides broad nutritional support vs single-compound ingredients. Practical fortification ingredient for daily wellness products.

Recovery and post-workout applications

Antioxidant-rich reds traditionally used for post-workout recovery — addressing exercise-induced oxidative stress and inflammation. MitoReds with ergothioneine amplification provides superior recovery support. Cellular energy support adds performance dimension to typical recovery applications.

Minimal flavor impact — formulation versatile

MitoReds has little taste of its own, so it blends into drinks and foods without a strong fruity flavor.

Pre-workout and hydration applications

MitoReds is used in some pre-workout and hydration products as a source of red-fruit polyphenols and ergothioneine. No MitoReds trial has measured exercise performance or recovery.

Mechanism of action

1

L-Ergothioneine mitochondrial accumulation

MitoPrime (L-ergothioneine) component accumulates in mitochondria via OCTN1 transporter. Provides mitochondrial-targeted antioxidant protection where free radical generation is highest. Same mechanism drives the 'Mito' positioning across NNB's MitoGreens and MitoReds products.

2

Anthocyanin nitric oxide support

Red and purple fruit anthocyanins support nitric oxide production via endothelial activation. NO is the primary vasodilator — supporting blood flow, cardiovascular health, and athletic performance. Mechanism explains MitoReds' cardiovascular positioning.

3

Polyphenol multi-pathway antioxidant

Nearly 30 red/purple botanicals provide multiple polyphenol classes — anthocyanins, proanthocyanidins, flavonoids, phenolic acids. Each polyphenol class targets different reactive oxygen species. Multi-pathway approach provides broader antioxidant coverage than single-compound interventions.

4

Cardiovascular polyphenol bioactivity

Red/purple polyphenols specifically have documented cardiovascular benefits — endothelial function support, blood pressure modulation, anti-platelet effects, LDL oxidation inhibition. The cardiovascular polyphenol class is distinct from green vegetable phytochemicals.

5

Exercise recovery free radical scavenging

Exercise generates reactive oxygen species — driving muscle damage and inflammation. Polyphenols and ergothioneine scavenge exercise-induced free radicals — supporting recovery without blunting training adaptation. Balance distinguishes MitoReds from high-dose isolated antioxidants that may impair adaptation.

Clinical trials

1
Ergothioneine mechanism and laboratory data (not a MitoReds trial)

Class evidence for L-ergothioneine (MitoPrime component) showing antioxidant superiority to glutathione, vitamin C, and CoQ10. Mitochondrial accumulation via OCTN1 transporter. Foundation for MitoReds' ergothioneine-amplified positioning.

Various — extensive preclinical and clinical research on L-ergothioneine.

L-ergothioneine outperforms major dietary antioxidants in capacity testing. OCTN1 transporter mediates mitochondrial accumulation. Body has dedicated retention mechanism — unique among antioxidants. Provides foundation for cellular energy and healthy aging applications.

2
Polyphenol class evidence from other products (not a MitoReds trial)

Class evidence on red and purple fruit polyphenols (anthocyanins, proanthocyanidins) cardiovascular effects. Documented benefits on endothelial function, blood pressure, lipid oxidation, and platelet function. Foundation for MitoReds' cardiovascular positioning.

Various — research base on dietary anthocyanin and polyphenol cardiovascular effects.

Red/purple fruit polyphenols consistently support cardiovascular health via multiple mechanisms — endothelial function, NO production, antioxidant activity, anti-inflammatory effects. Class evidence translates to MitoReds' nearly 30-botanical concentrated blend.

3
Marketing note on industry use (not a clinical trial)

MitoReds adoption in elite athletic and endurance supplements including Infinis Nutrition Hydration formula. Industry uptake reflects ingredient's performance positioning. Sports nutrition and hydration applications validate the cellular energy and recovery benefits.

Not applicable — industry adoption documentation across pre-workout, hydration, and recovery formulas.

MitoReds quickly becoming staple in elite athletic and endurance supplements. Provides antioxidant support, healthy energy levels, vitality, mitochondrial function, and immunity. Industry adoption validates the ingredient's positioning for performance applications beyond pure healthy aging.

Side effects and drug interactions

Common Potential side effects

Generally well-tolerated; concentrated red/purple botanical blend with strong food history.
Mild GI effects rare.
Non-GMO and gluten-free supports broad consumer applications.
L-ergothioneine component has GRAS status and excellent safety.
Minimal flavor impact supports broad formulation applications.
Pregnancy and lactation: dietary botanicals generally safe; consult clinician for supplemental concentrations.
Allergy considerations: verify individual botanical allergens for sensitive individuals.

Important Drug interactions

Anticoagulants (warfarin) — anthocyanin-rich polyphenols may have mild antiplatelet effects; consult prescriber.
Antihypertensive medications — polyphenols may have mild BP-lowering effects; monitor.
Diabetes medications — polyphenols may have mild glucose-lowering effects; monitor.
Iron supplements — polyphenols may inhibit iron absorption; separate timing.
Immunosuppressants — ergothioneine accumulates in immune cells; consult prescriber.
Antioxidant supplements — generally complementary; verify total intake.
Pregnancy and lactation: consult clinician.

Frequently asked questions about MitoReds™ (Ergothioneine-Amplified Reds Antioxidant Blend — NNB Nutrition)

What is MitoReds?

MitoReds™ is NNB Nutrition's antioxidant-rich reds powder built around MitoPrime® (L-ergothioneine). Its antioxidant strength has been measured only in test-tube capacity assays, and no human trial has tested MitoReds itself.

What is MitoReds used for?

MitoReds is researched primarily for Cardiovascular and Antioxidant. MitoReds combines MitoPrime (L-ergothioneine) with nearly 30 antioxidant-rich red/purple botanicals — delivering strong antioxidant capacity in laboratory testing.

What is the recommended dosage of MitoReds?

The clinically studied dose is MitoPrime ergothioneine 5-25 mg/day (from MitoPrime research). Always follow the product label and check with a healthcare provider for personal advice.

Is MitoReds safe, and does it have side effects?

For most healthy adults, MitoReds is well tolerated at studied doses. Reported effects can include: Generally well-tolerated; concentrated red/purple botanical blend with strong food history. Mild GI effects rare. It may also interact with some medications. MitoReds is not right for everyone, so check with a healthcare provider first if you are pregnant or breastfeeding, have a medical condition, or take prescription medication.

Does MitoReds interact with any medications?

Possible interactions include: Anticoagulants (warfarin) — anthocyanin-rich polyphenols may have mild antiplatelet effects; consult prescriber. Antihypertensive medications — polyphenols may have mild BP-lowering effects; monitor. If you take prescription medication, check with a pharmacist or doctor before using it.

How strong is the scientific evidence for MitoReds?

NutraSmarts rates the evidence for MitoReds as Preliminary (1 out of 5). It is backed by 3 clinical trials and 3 cited references summarized on this page. A higher rating reflects more, larger, and better-designed human studies.

References(3 citations)

Evidence ratings on NutraSmarts are based on the totality of human clinical research, with emphasis on randomized controlled trials, meta-analyses, and systematic reviews. The references below directly support claims made throughout this page.

  1. Halliwell B, Cheah IK, Tang RMY Ergothioneine - a diet-derived antioxidant with therapeutic potential. FEBS Letters. 2018;592(20):3357-3366. doi: 10.1002/1873-3468.13123.PubMedUsed to support: A review of L-ergothioneine, the MitoPrime® ingredient in MitoReds™. It describes ergothioneine as a diet-derived antioxidant that is actively taken up and retained by cells and reports high antioxidant activity in laboratory assays. It is a review of the single molecule, not a trial of MitoReds, and it reports no clinical antioxidant or ageing outcome in people taking the product.
  2. Tian X, Thorne JL, Moore JB Ergothioneine: an underrecognised dietary micronutrient required for healthy ageing? British Journal of Nutrition. 2023;129(1):104-114. doi: 10.1017/S0007114522003592.PubMedUsed to support: A review reporting that people with higher blood ergothioneine levels tend to have lower cardiovascular and overall mortality. This is an observational association seen across the ordinary diet, not a result of giving ergothioneine or MitoReds to anyone, so it cannot show that supplementation extends life or protects the heart.
  3. Dower JI, Geleijnse JM, Gijsbers L, Schalkwijk C, Kromhout D, Hollman PC Supplementation of the Pure Flavonoids Epicatechin and Quercetin Affects Some Biomarkers of Endothelial Dysfunction and Inflammation in (Pre)Hypertensive Adults: A Randomized Double-Blind, Placebo-Controlled, Crossover Trial. Journal of Nutrition. 2015;145(7):1459-63. doi: 10.3945/jn.115.211888.PubMedUsed to support: A randomized crossover trial in 37 (pre)hypertensive adults testing pure quercetin and pure epicatechin, not MitoReds. Over four weeks quercetin at 160 mg/day lowered the blood markers sE-selectin and IL-1beta. These are laboratory biomarkers, not measured heart events, and the compounds tested are different from those that define MitoReds.